Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amwell, Bowflex, Elekta, Element Biosciences, Instat, Leidos, Massive Bio, Nautilus, Onocoassist, Oula, Revity, Surgical Theater, Veristat.

Additional early-stage research and drug discovery news in brief, from: GRI, Ionctura, Mymd.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ayala, Basilea, Beam, Biosight, Eli Lilly, Geneuro, Gigagen, Gilead, Gravitas, Mablink, Microvascular, Oxford Nanopore, Pfizer, Qnovia, Seagen.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Centinel Spine, Davita, ERS Genomics, GE Healthcare, Glaukos, Google, Novo Nordisk, Pixium, Silony, Stuart Therapeutics, Syngene, Thermo Fisher.

Additional early-stage research and drug discovery news in brief, from: Enveric Biosciences, Gilead, Hookipa, Noxopharm, Palatin Technologies, Recludix.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advicenne, AN2, Avanzanite, Cessation, Currax, G1, Generation Bio, Ligand, Ovid, Talaris, Tourmaline, Traverse, Ultragenyx.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cellarity, Lifecore Biomedical, Microbot, SHL Medical, Vuze.

Additional early-stage research and drug discovery news in brief, from: Beyond Cancer, Biohaven, Corbus, Destiny, Myricx, Nextcure, Promontory, Storm, Venatorx.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Almirall, Alar Pharmaceuticals, Astellas Pharma, Biolabs Global, Biolinerx, Canariabio, Epimab Biotherapeutics, Gloria Biosciences , GC Biopharma, Glycotope, GPCR Therapeutics, Indivior, Immetas Therapeutics, Legochem, KPB Biosciences, Mitsui Fudosan, Novo Nordisk, Sosei Group, Specialised Therapeutics Asia, Taigen Biopharmaceuticals, Y.S.P. Industries.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aim, Bioaegis, Blue, Castlevax, Elevar, GRI, Immunos, Kyowa Kirin, Lumen, Lytix, Merck, Notable, Poolbeg, Revive, Sana, Seelos, Spark, Splicebio, VBL, Y-mabs.